Mystery designation of Rare Diseases
The prevalence of rare diseases is between 2 and 4%. Children between the ages of 3 and 5 are most at risk. Eighty percent of uncommon illnesses are genetic in character, therefore ordination sequencing-based designation offers an encouraging alternative for the management of rare diseases. Mystery designation for rare diseases is entire ordination sequencing. By analysing many genes, ordination sequencing, which has a diagnosis rate of 62.5%, will be utilised to analyse rare and unknown illnesses in order to identify the relevant.
Related Conference of Mystery designation of Rare Diseases
January 30-31, 2025
9th International Conference on Infectious Diseases: Control and Prevention
London, UK
May 21-22, 2025
12th International Conference on Infectious Diseases, Bacteriology and Antibiotics
Paris, France
June 16-17, 2025
5th International Conference on Microbiology and Infectious Diseases
Amsterdam, Netherlands
June 24-25, 2025
6th Annual Meeting on Infectious Diseases, Microbiology & Beneficial Microbes
Paris, France
October 06-07, 2025
13th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs
Las Vegas, USA
Mystery designation of Rare Diseases Conference Speakers
Recommended Sessions
- Clinical analysis and Treatment
- Infectious Diseases
- Mystery designation of Rare Diseases
- Neglected Tropical Diseases
- Orphan medicine
- Rare Cancer Diseases
- Rare Diseases
- Rare Diseases analysis
- Rare Diseases in Brain
- Rare Endocrine Genetic Diseases
- Rare Genetic Diseases
- Rare hematology Diseases
- Rare paediatrics Diseases
- Rare response Diseases
- Rare Skin Diseases
- Treatment for Rare Diseases
Related Journals
Are you interested in
- 1.Infectious Diseases and Neuro Infectious Diseases - Infectious Diseases_2025 (Canada)
- 10. HIV/AIDS - Infectious Diseases_2025 (Canada)
- 11. Pediatric Infectious Diseases/ Childhood Infectious Diseases - Infectious Diseases_2025 (Canada)
- 12. Respiratory Diseases - Infectious Diseases_2025 (Canada)
- 13. Sexually Transmitted Diseases/ Sexually Transmitted Infections - Infectious Diseases_2025 (Canada)
- 14. Viral Infectious Diseases - Infectious Diseases_2025 (Canada)
- 15. Malaria and Hepatitis - Infectious Diseases_2025 (Canada)
- 16. Immunology of Infections - Infectious Diseases_2025 (Canada)
- 17. Vaccines and Vaccination - Infectious Diseases_2025 (Canada)
- 18. Tuberculosis - Infectious Diseases_2025 (Canada)
- 19. New Antiviral, Antibacterial and Antifungal Agents - Infectious Diseases_2025 (Canada)
- 2. Coronavirus(nCOV) - Infectious Diseases_2025 (Canada)
- 20. Nosocomial Infections - Infectious Diseases_2025 (Canada)
- 21. Parasitic Diseases - Infectious Diseases_2025 (Canada)
- 22. Surgical Site Infections - Infectious Diseases_2025 (Canada)
- 3. Infectious Diseases Prevention, Control and Cure - Infectious Diseases_2025 (Canada)
- 4. Bacterial & Fungal Infectious Diseases - Infectious Diseases_2025 (Canada)
- 5. Rare Infectious Diseases and Immune Deficiencies - Infectious Diseases_2025 (Canada)
- 6. Rare Diseases in Cancer and Aging - Infectious Diseases_2025 (Canada)
- 7. Global Trends in Emerging Infectious Diseases - Infectious Diseases_2025 (Canada)
- 8. Ebola and Zika Viral Infections - Infectious Diseases_2025 (Canada)
- 9. Clinical Research and Public Awareness - Infectious Diseases_2025 (Canada)
- A prospective study of dermatological infections - Emerging Infectious Diseases 2025 (Canada)
- Advancement in the Diagnosis of Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Advancements in Vaccines and Therapeutics - Infectious Diseases 2025 (France)
- Antibiotics and Anti-viral - Euro Infectious Diseases 2025 (Netherlands)
- Antigen-Antibody Reactions - Infectious Diseases 2025 (France)
- Antimicrobial Resistance - Emerging Infectious Diseases 2025 (Canada)
- Antimicrobial Stewardship/Antimicrobial Resistance - Infection Prevention 2025 (UK)
- Bacterial Diseases - Euro Infectious Diseases 2025 (Netherlands)
- Bacterial Infections and Diseases - Infectious Diseases 2025 (France)
- Bacterial Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Bacterial Infectious Diseases - Infection Congress 2025 (Germany)
- Bacterial, Parasitic and Fungal Infections - Infection Prevention 2025 (UK)
- Biofertilizers - Infectious Diseases 2025 (France)
- Biomarkers for Rare Disease Diagnosis and Treatment - Rare Diseases Congress 2025 (Netherlands)
- Biomedical Research - Rare Diseases Congress 2025 (Netherlands)
- Blood Borne Infections/Sepsis/Septicaemia - Infection Prevention 2025 (UK)
- Bloodborne infectious diseases, - Infection Congress 2025 (Germany)
- Cardiovascular Diseases and Disorders - Emerging Infectious Diseases 2025 (Canada)
- Causes and Symptoms of Infections - Infection Prevention 2025 (UK)
- Causes and Symptoms of Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Challenges of Living with a Rare Disease - Rare Diseases Congress 2025 (Netherlands)
- Changing Patterns of Infectious Diseases - Emerging Infectious Diseases 2025 (Canada)
- Clinical analysis and Treatment - WORLD RARE DISEASES 2025 (Czech Republic)
- Clinical and Case Reports - INFECTIOUS DISEASES-2025 (France)
- Clinical Case Reports and Case Studies - Rare Diseases Congress 2025 (Netherlands)
- Clinical Management of Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Clinical Research on Orphan Drugs - Rare Diseases Congress 2025 (Netherlands)
- Coronavirus Disease (COVID-19) - INFECTIOUS DISEASES-2025 (France)
- COVID-19 - Infectious Diseases 2025 (France)
- COVID-19 Infection - Infection Congress 2025 (Germany)
- Covid_19 Infections - Infection Prevention 2025 (UK)
- Dental diseases & Infections - Emerging Infectious Diseases 2025 (Canada)
- Dermatological Infections - Euro Infectious Diseases 2025 (Netherlands)
- Diabetes and Wound Care - Emerging Infectious Diseases 2025 (Canada)
- Diagnosing infectious diseases - Infection Congress 2025 (Germany)
- Diagnosis of infectious Diseases - Infection Prevention 2025 (UK)
- Diagnostics and Laboratory Techniques - Emerging Infectious Diseases 2025 (Canada)
- Different Types of Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Disinfection and Sterilization - Infection Control 2025 (UK)
- Drug Discovery for Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Ebola virus disease (EVD) & Zika virus - Infection Congress 2025 (Germany)
- Emerging and Re-Emerging Infections - Infection Congress 2025 (Germany)
- Emerging and Re-Emerging Infections - Infection Prevention 2025 (UK)
- Emerging Infectious Diseases - Infection Control 2025 (UK)
- Emerging Technologies in Rare Disease Research - Rare Diseases Congress 2025 (Netherlands)
- Epidemiology - INFECTIOUS DISEASES-2025 (France)
- Epidemiology - Infection Prevention 2025 (UK)
- Epidemiology and Surveillance - Emerging Infectious Diseases 2025 (Canada)
- Epidemiology of Infectious Diseases - Infection Congress 2025 (Germany)
- Food and waterborne Infections - Infection Congress 2025 (Germany)
- Functional Genomics and Gene Therapy for Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Fungal Infections - Infectious Diseases 2025 (France)
- Fungal Infections - Euro Infectious Diseases 2025 (Netherlands)
- Fungal Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Fungal Infectious Diseases - Infection Congress 2025 (Germany)
- Gastrointestinal and urinary tract infections - Infection Congress 2025 (Germany)
- Gastrointestinal and Urinary Tract Infections - Infection Prevention 2025 (UK)
- Gene Expression - Infectious Diseases 2025 (France)
- Genetic Testing and Counselling of Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Global Climatic Change and Emerging Infectious Diseases - Emerging Infectious Diseases 2025 (Canada)
- Global Health Security - Emerging Infectious Diseases 2025 (Canada)
- Global hotspots and correlates of emerging zoonotic diseases - Emerging Infectious Diseases 2025 (Canada)
- Global Trends in Emerging Infections - Infection Prevention 2025 (UK)
- Health Economics and Market Access for Orphan Drugs - Rare Diseases Congress 2025 (Netherlands)
- Hepatitis Prevention - Infection Control 2025 (UK)
- Hepatitis Prevention - Infection Prevention 2025 (UK)
- HIV Prevention, Treatment and Cure - Infection Control 2025 (UK)
- Human Monkeypox: An Emerging Zoonosis - Emerging Infectious Diseases 2025 (Canada)
- Immunizations and Vaccination - Infection Prevention 2025 (UK)
- Infection Control Bacteriology - Infection Control 2025 (UK)
- Infection Control Business - Infection Control 2025 (UK)
- Infection Control in Critical Care - Infection Prevention 2025 (UK)
- Infection Control in Dental - Infection Control 2025 (UK)
- Infection Control Precautions - Infection Control 2025 (UK)
- Infection Control Procedures - Infection Prevention 2025 (UK)
- Infection Control Treatment & Diagnosis - Infection Control 2025 (UK)
- Infection Prevention and Control - Euro Infectious Diseases 2025 (Netherlands)
- Infection Prevention and Control - Infection Prevention 2025 (UK)
- Infection Treatment and Control - Infection Control 2025 (UK)
- Infection, Immunity and Inflammation - INFECTIOUS DISEASES-2025 (France)
- Infection, Immunity and Inflammation - INFECTIOUS DISEASES-2025 (France)
- Infectious Disease - Euro Infectious Diseases 2025 (Netherlands)
- Infectious Disease Pathology - Infection Control 2025 (UK)
- Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Infectious Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Infectious Diseases - Infection Congress 2025 (Germany)
- Infectious Diseases and Cancer - Infectious Diseases 2025 (France)
- Infectious Diseases and Immune Deficiencies - Rare Diseases Congress 2025 (Netherlands)
- Infectious Diseases Epidemiology - INFECTIOUS DISEASES-2025 (France)
- Infectious Diseases Prevention, Control and Cure - INFECTIOUS DISEASES-2025 (France)
- Influenza and Diagnostic Approaches - Infection Control 2025 (UK)
- Internal Medicine for Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Introduction and Causes of New Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Mutations - Infectious Diseases 2025 (France)
- Mystery designation of Rare Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Neglected Tropical Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Neuro infections - Infection Congress 2025 (Germany)
- Neuro Infections - Infection Prevention 2025 (UK)
- Neuro Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Neurological Infections - Euro Infectious Diseases 2025 (Netherlands)
- Nosocomial Infections & Control - Infection Control 2025 (UK)
- Nosocomial Infections & Control - INFECTIOUS DISEASES-2025 (France)
- Nosocomial Infections and Control - Infection Prevention 2025 (UK)
- Nosocomial Infections and Their Control Strategies - Emerging Infectious Diseases 2025 (Canada)
- Nursing Infection Control - Infection Control 2025 (UK)
- Ophthalmological Infections - Euro Infectious Diseases 2025 (Netherlands)
- Orphan Drugs Potentiality - Rare Diseases Congress 2025 (Netherlands)
- Orphan medicine - WORLD RARE DISEASES 2025 (Czech Republic)
- Outbreak Investigation and Response - Emerging Infectious Diseases 2025 (Canada)
- Paediatric Infectious Diseases - Euro Infectious Diseases 2025 (Netherlands)
- Parasitic Infections - Infectious Diseases 2025 (France)
- Parasitic Infections - Euro Infectious Diseases 2025 (Netherlands)
- Parasitic Infectious Diseases - Infection Congress 2025 (Germany)
- Parasitology & Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Pediatric Infectious Diseases - Infection Control 2025 (UK)
- Pediatric Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Pediatric Infectious Diseases - Emerging Infectious Diseases 2025 (Canada)
- Perspectives on Gastrointestinal Infections - Emerging Infectious Diseases 2025 (Canada)
- Pharmacology of Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Plants Diseases and Infection Control - Infection Prevention 2025 (UK)
- Practical Guidelines - Infection Control 2025 (UK)
- Practices & Awareness - Infection Control 2025 (UK)
- Preventive Measures - Euro Infectious Diseases 2025 (Netherlands)
- Prion Diseases - Infectious Diseases 2025 (France)
- Probiotics and Prebiotics - Infectious Diseases 2025 (France)
- Public Health - Euro Infectious Diseases 2025 (Netherlands)
- Public Health Policy and Preparedness - Emerging Infectious Diseases 2025 (Canada)
- Pulmonary and Chest Infections - Infection Congress 2025 (Germany)
- Pulmonary Infection Therapy - Infection Congress 2025 (Germany)
- Rare Autoimmune Disorders - Rare Diseases Congress 2025 (Netherlands)
- Rare Bone Diseases - Rare Diseases Congress 2025 (Netherlands)
- Rare Cancer - Rare Diseases Congress 2025 (Netherlands)
- Rare Cancer Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Rare Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Rare Diseases analysis - WORLD RARE DISEASES 2025 (Czech Republic)
- Rare Diseases and Orphan Drugs - Rare Diseases Congress 2025 (Netherlands)
- Rare Diseases in Brain - WORLD RARE DISEASES 2025 (Czech Republic)
- Rare Diseases of the Heart and Vessels - Rare Diseases Congress 2025 (Netherlands)
- Rare Endocrine Genetic Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Rare Genetic Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Rare hematology Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Rare Neurological Disorders - Rare Diseases Congress 2025 (Netherlands)
- Rare Nutritional and Metabolic Diseases - Rare Diseases Congress 2025 (Netherlands)
- Rare Paediatric Diseases - Rare Diseases Congress 2025 (Netherlands)
- Rare paediatrics Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Rare response Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Rare Skin Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Rare Skin Diseases - Rare Diseases Congress 2025 (Netherlands)
- Regulatory Considerations for Developing Orphan Drugs - Rare Diseases Congress 2025 (Netherlands)
- Research on Medicine and Vaccine for Covid-19 - INFECTIOUS DISEASES-2025 (France)
- Respiratory Infectious Diseases and Therapy - Infection Prevention 2025 (UK)
- Respiratory tract infections - Euro Infectious Diseases 2025 (Netherlands)
- Risk Factors & Prevention - Infection Control 2025 (UK)
- SARS and MERS: Recent Insights into Emerging Coronaviruses - Emerging Infectious Diseases 2025 (Canada)
- Sexually Transmitted Diseases (STDs) and Infections (STIs) - Infectious Diseases 2025 (France)
- Sexually transmitted diseases STDs - Infection Congress 2025 (Germany)
- The Science of SARS-CoV-2 - Emerging Infectious Diseases 2025 (Canada)
- Therapeutics and Treatment Strategies - Emerging Infectious Diseases 2025 (Canada)
- Treatment and Advanced Therapies for Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Treatment for Rare Diseases - WORLD RARE DISEASES 2025 (Czech Republic)
- Treatment for Tuberculosis - Infection Control 2025 (UK)
- Tropical diseases - Euro Infectious Diseases 2025 (Netherlands)
- Tropical Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Urinary Tract Infection - Euro Infectious Diseases 2025 (Netherlands)
- Vaccine Research & Development - Infection Control 2025 (UK)
- Vaccines - Euro Infectious Diseases 2025 (Netherlands)
- Vaccines and Immunization - Emerging Infectious Diseases 2025 (Canada)
- Vaccines and Vaccination - INFECTIOUS DISEASES-2025 (France)
- Vaccines and Vaccination for Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Vector-borne diseases: New Approaches to Control Vector from disease transmission - Emerging Infectious Diseases 2025 (Canada)
- Veterinary Diseases - INFECTIOUS DISEASES-2025 (France)
- Veterinary Infection Control - Infection Control 2025 (UK)
- Veterinary Infectious Diseases - Infectious Diseases 2025 (France)
- Viral Infections - Euro Infectious Diseases 2025 (Netherlands)
- Viral Infections and Diseases - Infectious Diseases 2025 (France)
- Viral Infections and Recent Advancements - Infection Prevention 2025 (UK)
- Viral Infectious Diseases - INFECTIOUS DISEASES-2025 (France)